R&D Technical White Paper

Salt Lake City (October 22, 2024) A recent academic publication in the journal GeroScience by authors Sandalova, E.; Li, H.; and Guan, L. identifies a significant discrepancy between the amount of NMN (Nicotinamide mononucleotide) listed on retail supplement labels and the actual amount of NMN in the formulas. NMN is a key ingredient in 4Life’s newest product: 4Life Transfer Factor AgePro^®.

4Life Chief Scientific Officer Dr. David Vollmer: “Testing for the amount of NMN in 4Life Transfer Factor AgePro is an important part of the manufacturing process. Due to variabilities in blending and encapsulation, we formulate with additional NMN to ensure 4Life Transfer Factor AgePro always meets our label claim.”

Third-party quality testing protocols for 4Life’s NMN purity at the raw ingredient level is 99%. In the finished product, 4Life testing reveals 104% NMN strength.

The company’s commitment to the strictest quality standards extends back to the beginning of 4Life in 1998. Earlier this year, an independent NSF^® audit of 4Life GMP manufacturing facilities returned an “A” grade.

Vollmer: “Whereas many NMN supplements in the marketplace have little or varying amounts, 4Life Transfer Factor AgePro contains the exact amount of NMN or more than indicated on the label.”

CLICK HERE FOR TECHNICAL WHITE PAPER.

4Life, The Immune System Company^®, and the first to bring transfer factor research to market, has offices in dozens of countries to serve the company’s worldwide customers.

For more information:
Calvin Jolley
Vice President Corporate Communications
4Life Research
[email protected]